Loading stock…

Aveanna Healthcare Holdings Inc. (AVAH) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Aveanna Healthcare Holdings Inc.

AVAHMarket cap $2.69BPrice $12.3

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Provides home-based care for medically fragile children and adults, including skilled nursing and therapy. One of the largest pediatric home care providers in the US, filling gaps left by hospital staffing shortages.

In Bastion Portfolios?

52W Return+25%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+11%7

Revenue Forecast

Rev CAGR (1y)+11%6

Rev CAGR (3y)+8%6

Rev CAGR (5y)+6%5

Earnings Forecast

EPS Growth Y+1-24%2

EPS Growth Y+2+12%7

EPS Growth Y+3+10%6

Quality

Margins

EBIT Margin12%5

Net Income Margin11%6

Free Cash Flow Margin6%4

Debt

Net Debt/EBITDA4.12

Efficiency

ROE191%10

ROA14%9

Earnings Stability22

GEAR+AVERAGE43

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)146

P/E Ratio (Forward 3y)126

P/BV9.32

EV Multiples

EV/EBITDA Fwd115

EV/EBIT Fwd118

Yield

Free Cash Flow Yield5.9%7

Dividend Yieldna–

Momentum

Short term

1 month return-10%3

3 month return+28%10

YTD return+51%9

Mid term

Price vs 52wHigh84%6

1 year return+38%8

Long term

3 year return+970%10

5 year return+69%7

Risk Shield

Price Risk

Beta1.23

Volatility49%3

Free Cash Flow

Free Cash Flow Margin6%4

Free Cash Flow Yield5.9%7

Quality

ROCE20%9

Earnings Stability22

Net Debt/EBITDA4.12

02Growth

Is it actually growing, and how fast?

AVAHAveanna Healthcare Holdings

Revenue FY26$2.4B

GROWTH RATING↗

AVERAGE53 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-24%2

EPS growth, FY28E+12%7

EPS growth, FY29E+10%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 53% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 11%/yr over the last 3 years and is set to keep growing around 8%/yr.

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 8%/yr). One year dips: EPS falls 24% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower. The one thing to watch: the long-term outlook is only average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG79 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%3

3-month return+28%10

YTD return+51%9

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+38%8

3-year return+970%10

5-year return+69%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +970% over three years and +69% over five, ahead of 80% of the market.

It's up 38% over the past year, but 16% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+28%) and so far this year (+51%).

WATCH

None flagged.

WEAKNESSES

The stock is underperforming over the past month (-10%).

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on Aveanna Healthcare Holdings Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

AVAHAveanna Healthcare Holdings

Revenue FY26$2.4B

GROWTH RATING↗

AVERAGE53 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-24%2

EPS growth, FY28E+12%7

EPS growth, FY29E+10%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 53% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 11%/yr over the last 3 years and is set to keep growing around 8%/yr.

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 8%/yr). One year dips: EPS falls 24% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower. The one thing to watch: the long-term outlook is only average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG79 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%3

3-month return+28%10

YTD return+51%9

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+38%8

3-year return+970%10

5-year return+69%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +970% over three years and +69% over five, ahead of 80% of the market.

It's up 38% over the past year, but 16% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+28%) and so far this year (+51%).

WATCH

None flagged.

WEAKNESSES

The stock is underperforming over the past month (-10%).

BOTTOM LINE

Momentum Leader

04Value

Are you paying a fair price for it?

Stop guessing on Aveanna Healthcare Holdings Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community